ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,166.00
1.81%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36684
-0.40%
Bitcoin
59,292.25
1.81%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Osiris Therape (MM) (OSIR)

  7. Osiris Therape (MM) (OSIR) News

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OSIR
DateTimeSourceHeadlineSymbolCompany
04/29/20193:13PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
04/17/20198:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:36AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:19AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
04/17/20198:05AMGlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
04/17/20195:08AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
04/17/20195:08AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
04/16/20198:02AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
04/12/20197:57AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
04/10/20198:34AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
04/10/20198:30AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
03/27/20194:20PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
03/27/20194:13PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
03/20/20196:43AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
03/20/20196:33AMEdgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
03/15/20195:13PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
03/15/20198:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
03/12/20194:10PMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
03/12/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
03/12/20194:03PMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
03/12/201912:14PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
03/12/20198:33AMPR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
03/12/20198:22AMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
 Showing the most relevant articles for your search:NASDAQ:OSIR

Your Recent History

NASDAQ
JAGX
Jaguar Health
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
SPZI
Spooz (PK)
USOTC
ILST
International Star (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
ACRL
Atacama Resources (PK)
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
MULN
Mullen Automotive
NASDAQ
HOLO
MicroCloud Hologram
USOTC
FBEC
FBEC Worldwide (PK)
NASDAQ
VERB
Verb Technology
USOTC
BABL
Buildablock (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved